European Biotech

Forbion Secures €2.3 Billion for Biotech Investment, Countering European Capital Shortage

Venture capital firm Forbion has raised €2.3 billion for two new investment funds, marking its largest fundraise to date and injecting substantial capital into the European life sciences sector. This significant move aims to support approximately 30 high-potential biotech companies and counter the persistent funding challenges in the region.